The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement

Irina Caminschi, Anna I. Proietto, Fatma Ahmet, +19

Blood

Th1 and Th17 Cells Induce Proliferative Glomerulonephritis

Shaun A. Summers, Oliver M. Steinmetz, Ming Li, +7

Journal of the American Society of Nephrology

Glomerular DiseaseGlomerulonephritisInflammationCytokineAutoimmune Disease +12

Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III

Jenny Björkqvist, Steven de Maat, Urs Lewandrowski, +11

Journal of Clinical Investigation

Vascular DiseaseImmunologyPathologyInflammationThrombosis +16

Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC

Samantha J. Busfield, Mark Biondo, M. Wong, +13

Leukemia

Hematological MalignancyMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaMalignant Blood DisorderImmunology +7

The C-Type Lectin Clec12A Present on Mouse and Human Dendritic Cells Can Serve as a Target for Antigen Delivery and Enhancement of Antibody Responses

Mireille H. Lahoud, Anna I. Proietto, Fatma Ahmet, +14

The Journal of Immunology

Anti-clec12a MabImmunologyImmune RegulationImmunologic MechanismAntigen Processing +16

ISCOMATRIX vaccines mediate CD8⁺ T‐cell cross‐priming by a MyD88‐dependent signaling pathway

Nicholas S. Wilson, Becky Yang, Adriana Baz Morelli, +13

Immunology and Cell Biology

ImmunologyImmunoeditingImmunodominanceAntigen ProcessingCd4 T Cell Responses +21

ISCOMATRIX Adjuvant Induces Efficient Cross-Presentation of Tumor Antigen by Dendritic Cells via Rapid Cytosolic Antigen Delivery and Processing via Tripeptidyl Peptidase II

Max Schnurr, Martin Orban, Neil C. Robson, +6

The Journal of Immunology

Vaccine AgImmunologyImmunoeditingPathologyAntigen Processing +16

Supplementary Figure 2

Nicholas S. Wilson, Becky Yang, Adriana Baz Morelli, +13

Geometry Of NumberGeometrySupplementary Figure 2

Dual Mechanism of Interleukin-3 Receptor Blockade by an Anti-Cancer Antibody

Sophie E. Broughton, Timothy R. Hercus, Matthew P. Hardy, +16

Cell Reports

CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors

Con Panousis, Urmi Dhagat, Kirsten M. Edwards, +18

mAbs

Inflammatory Lung DiseaseLung InflammationImmune RegulationImmunologyImmunologic Mechanism +22